We aim to consistently deliver superior investment performance. We think deeply and independently – constantly pursuing excellence for our clients.
We are a specialist investment management firm based in Cape Town. Founded in 2001, we manage funds across the risk spectrum for sophisticated institutional and private investors.
Chronic illness is a growing market for Novo Nordisk
“Novo Nordisk’s modern innovations have focused on insulin engineering to develop solutions that mimic the natural profile of insulin in the blood. Its research and development spend has outpaced competitors, resulting in sustained market share gains, rising from 20% of the total diabetes care market in 2006 to more than 27% in 2016.”